(Q53292491)

English

Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

cerebrospinal fluid

0 references

amyotrophic lateral sclerosis

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

Hilkka Soininen

3

object named as

Soininen H

1 reference

Europe PubMed Central

13 May 2018

author name string

P. Hartikainen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

K. J. Reinikainen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

J. Sirviö

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

R. Soikkeli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

P. J. Riekkinen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1347220

16 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1347220

16 September 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

Journal of neural transmission. Parkinson's disease and dementia section

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

4

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

1

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

53-68

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

https://scigraph.springernature.com/pub.10.1007/bf02257622

0 references

Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

CSF somatostatin-like immunoreactivity in dementia

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

beta-Endorphin cerebrospinal fluid decrease in untreated parkinsonian patients

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1007%2FBF02257622

21 January 2018

Identifiers

10.1007/BF02257622

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

1 reference

Europe PubMed Central

13 May 2018

http://europepmc.org/abstract/MED/1347220

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53292491&oldid=1889719196"